Effect of telmisartan on hypertensive dementia patients: an observational study
Background: This was a prospective observational study done to observe the effects of telmisartan on cognitive function in hypertensive dementia patients.Methods: The study included new diagnosed hypertensive and normotensive dementia patients. Patients comprised of four groups; hypertensive dementi...
Gespeichert in:
Veröffentlicht in: | International journal of basic and clinical pharmacology 2020-07, Vol.9 (7), p.1038 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7 |
container_start_page | 1038 |
container_title | International journal of basic and clinical pharmacology |
container_volume | 9 |
creator | Keshri, Umashanker Prasad Ranjan, Ravi Guria, Risi Tuhin Kumar, Paramveer Rajnish, Kumar Gari, Manju |
description | Background: This was a prospective observational study done to observe the effects of telmisartan on cognitive function in hypertensive dementia patients.Methods: The study included new diagnosed hypertensive and normotensive dementia patients. Patients comprised of four groups; hypertensive dementia patients taking telmisartan (group 1), hypertensive dementia patients taking donepezil and telmisartan (group 2), normotensive dementia patients taking donepezil (group 3) and normotensive dementia patients taking drugs which does not affect memory (group 4).Cognitive function of four groups were compared to each other at 4, 8 and 12 weeks.Results: In group 1, 2 and 3 mini-mental state examination (MMSE) scores has increased by 1.69, 16.81, and 13.28 percent and in group 4 there is decrease in MMSE score by 6.03 percent in 12 weeks.Conclusions: In this study we can conclude that telmisartan has dementia preventing propensity which is better than placebo but not as good as donepezil. |
doi_str_mv | 10.18203/2319-2003.ijbcp20202937 |
format | Article |
fullrecord | <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_18203_2319_2003_ijbcp20202937</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_18203_2319_2003_ijbcp20202937</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1713-170c20ea9bb76ad2090551b1df567eb5b84f4f4d48532d7987f12c2a57b6114e3</originalsourceid><addsrcrecordid>eNpVUMlqwzAUFKWFhjT_oB9w-p5kW1JvJaQLBHJpz0ayn6iDNyQ14L-v0-VQ5jDDMAzMMMYRtqgFyHsh0WQCQG7bk6snAQuMVFdsJYQyGSgN14v-S92yTYwnAECBWmuzYse991QnPnqeqOvbaEOyAx8H_jFPFBINsT0Tb6inIbWWTza1i4oP_JJykcJ5ccbBdjymz2a-YzfedpE2v7xm70_7t91Ldjg-v-4eD1mNCmWGCmoBZI1zqrSNAANFgQ4bX5SKXOF07hc0uS6kaJTRyqOohS2UKxFzkmumf3rrMMYYyFdTaHsb5gqh-v6muqyuLqurf9_ILyL5WXg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Effect of telmisartan on hypertensive dementia patients: an observational study</title><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Keshri, Umashanker Prasad ; Ranjan, Ravi ; Guria, Risi Tuhin ; Kumar, Paramveer ; Rajnish, Kumar ; Gari, Manju</creator><creatorcontrib>Keshri, Umashanker Prasad ; Ranjan, Ravi ; Guria, Risi Tuhin ; Kumar, Paramveer ; Rajnish, Kumar ; Gari, Manju</creatorcontrib><description>Background: This was a prospective observational study done to observe the effects of telmisartan on cognitive function in hypertensive dementia patients.Methods: The study included new diagnosed hypertensive and normotensive dementia patients. Patients comprised of four groups; hypertensive dementia patients taking telmisartan (group 1), hypertensive dementia patients taking donepezil and telmisartan (group 2), normotensive dementia patients taking donepezil (group 3) and normotensive dementia patients taking drugs which does not affect memory (group 4).Cognitive function of four groups were compared to each other at 4, 8 and 12 weeks.Results: In group 1, 2 and 3 mini-mental state examination (MMSE) scores has increased by 1.69, 16.81, and 13.28 percent and in group 4 there is decrease in MMSE score by 6.03 percent in 12 weeks.Conclusions: In this study we can conclude that telmisartan has dementia preventing propensity which is better than placebo but not as good as donepezil.</description><identifier>ISSN: 2319-2003</identifier><identifier>EISSN: 2279-0780</identifier><identifier>DOI: 10.18203/2319-2003.ijbcp20202937</identifier><language>eng</language><ispartof>International journal of basic and clinical pharmacology, 2020-07, Vol.9 (7), p.1038</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1713-170c20ea9bb76ad2090551b1df567eb5b84f4f4d48532d7987f12c2a57b6114e3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,27929,27930</link.rule.ids></links><search><creatorcontrib>Keshri, Umashanker Prasad</creatorcontrib><creatorcontrib>Ranjan, Ravi</creatorcontrib><creatorcontrib>Guria, Risi Tuhin</creatorcontrib><creatorcontrib>Kumar, Paramveer</creatorcontrib><creatorcontrib>Rajnish, Kumar</creatorcontrib><creatorcontrib>Gari, Manju</creatorcontrib><title>Effect of telmisartan on hypertensive dementia patients: an observational study</title><title>International journal of basic and clinical pharmacology</title><description>Background: This was a prospective observational study done to observe the effects of telmisartan on cognitive function in hypertensive dementia patients.Methods: The study included new diagnosed hypertensive and normotensive dementia patients. Patients comprised of four groups; hypertensive dementia patients taking telmisartan (group 1), hypertensive dementia patients taking donepezil and telmisartan (group 2), normotensive dementia patients taking donepezil (group 3) and normotensive dementia patients taking drugs which does not affect memory (group 4).Cognitive function of four groups were compared to each other at 4, 8 and 12 weeks.Results: In group 1, 2 and 3 mini-mental state examination (MMSE) scores has increased by 1.69, 16.81, and 13.28 percent and in group 4 there is decrease in MMSE score by 6.03 percent in 12 weeks.Conclusions: In this study we can conclude that telmisartan has dementia preventing propensity which is better than placebo but not as good as donepezil.</description><issn>2319-2003</issn><issn>2279-0780</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpVUMlqwzAUFKWFhjT_oB9w-p5kW1JvJaQLBHJpz0ayn6iDNyQ14L-v0-VQ5jDDMAzMMMYRtqgFyHsh0WQCQG7bk6snAQuMVFdsJYQyGSgN14v-S92yTYwnAECBWmuzYse991QnPnqeqOvbaEOyAx8H_jFPFBINsT0Tb6inIbWWTza1i4oP_JJykcJ5ccbBdjymz2a-YzfedpE2v7xm70_7t91Ldjg-v-4eD1mNCmWGCmoBZI1zqrSNAANFgQ4bX5SKXOF07hc0uS6kaJTRyqOohS2UKxFzkmumf3rrMMYYyFdTaHsb5gqh-v6muqyuLqurf9_ILyL5WXg</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Keshri, Umashanker Prasad</creator><creator>Ranjan, Ravi</creator><creator>Guria, Risi Tuhin</creator><creator>Kumar, Paramveer</creator><creator>Rajnish, Kumar</creator><creator>Gari, Manju</creator><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20200701</creationdate><title>Effect of telmisartan on hypertensive dementia patients: an observational study</title><author>Keshri, Umashanker Prasad ; Ranjan, Ravi ; Guria, Risi Tuhin ; Kumar, Paramveer ; Rajnish, Kumar ; Gari, Manju</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1713-170c20ea9bb76ad2090551b1df567eb5b84f4f4d48532d7987f12c2a57b6114e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Keshri, Umashanker Prasad</creatorcontrib><creatorcontrib>Ranjan, Ravi</creatorcontrib><creatorcontrib>Guria, Risi Tuhin</creatorcontrib><creatorcontrib>Kumar, Paramveer</creatorcontrib><creatorcontrib>Rajnish, Kumar</creatorcontrib><creatorcontrib>Gari, Manju</creatorcontrib><collection>CrossRef</collection><jtitle>International journal of basic and clinical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Keshri, Umashanker Prasad</au><au>Ranjan, Ravi</au><au>Guria, Risi Tuhin</au><au>Kumar, Paramveer</au><au>Rajnish, Kumar</au><au>Gari, Manju</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of telmisartan on hypertensive dementia patients: an observational study</atitle><jtitle>International journal of basic and clinical pharmacology</jtitle><date>2020-07-01</date><risdate>2020</risdate><volume>9</volume><issue>7</issue><spage>1038</spage><pages>1038-</pages><issn>2319-2003</issn><eissn>2279-0780</eissn><abstract>Background: This was a prospective observational study done to observe the effects of telmisartan on cognitive function in hypertensive dementia patients.Methods: The study included new diagnosed hypertensive and normotensive dementia patients. Patients comprised of four groups; hypertensive dementia patients taking telmisartan (group 1), hypertensive dementia patients taking donepezil and telmisartan (group 2), normotensive dementia patients taking donepezil (group 3) and normotensive dementia patients taking drugs which does not affect memory (group 4).Cognitive function of four groups were compared to each other at 4, 8 and 12 weeks.Results: In group 1, 2 and 3 mini-mental state examination (MMSE) scores has increased by 1.69, 16.81, and 13.28 percent and in group 4 there is decrease in MMSE score by 6.03 percent in 12 weeks.Conclusions: In this study we can conclude that telmisartan has dementia preventing propensity which is better than placebo but not as good as donepezil.</abstract><doi>10.18203/2319-2003.ijbcp20202937</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2319-2003 |
ispartof | International journal of basic and clinical pharmacology, 2020-07, Vol.9 (7), p.1038 |
issn | 2319-2003 2279-0780 |
language | eng |
recordid | cdi_crossref_primary_10_18203_2319_2003_ijbcp20202937 |
source | Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals |
title | Effect of telmisartan on hypertensive dementia patients: an observational study |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T06%3A21%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20telmisartan%20on%20hypertensive%20dementia%20patients:%20an%20observational%20study&rft.jtitle=International%20journal%20of%20basic%20and%20clinical%20pharmacology&rft.au=Keshri,%20Umashanker%20Prasad&rft.date=2020-07-01&rft.volume=9&rft.issue=7&rft.spage=1038&rft.pages=1038-&rft.issn=2319-2003&rft.eissn=2279-0780&rft_id=info:doi/10.18203/2319-2003.ijbcp20202937&rft_dat=%3Ccrossref%3E10_18203_2319_2003_ijbcp20202937%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |